Sort
261,768 grants matching “gene therapy”
Genetics of Alzheimer's Disease in Israeli Arabs
$1,063,195Robert Paul Friedland · Case Western Reserve University · R01 · FY2008 · AG
Optimization of gene transfer and gene editing safety and efficacy focusing on the NHP model
$1,063,173Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Investigating Correlates and Therapeutics of Fatigue in Cancer Patients
$1,063,153Leorey Saligan · National Institute Of Nursing Research · ZIA · FY2017 · NR
Functional & Structural Connectivity and Neuro Modulation in Alcohol Use Disorder
$1,063,137Abdolreza Momenan · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Advancing RNA Therapeutics for Huntingtonâs Disease
$1,063,015Neil Aronin · Univ Of Massachusetts Med Sch Worcester · U01 · FY2024 · NS
Novel small molecules for protection against doxorubicin cardiotoxicity in TNBC
$1,062,913Cathy A Swindlehurst · Novomedix, Inc. · R44 · FY2022 · HL
Treatment Research Investigating Depression Effects on Neuroimmune Targets (TRIDENT)
$1,062,625Adam Wayne Carrico · Florida International University · R01 · FY2024 · MH
Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients.
$1,062,505Srikanth Singamsetty · Phoenix Nest, Inc. · R44 · FY2025 · NS
Telomere Diseases
$1,062,495Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Immunotherapeutic Interventions of AIDS and Cancer
$1,062,472Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Effects of IL-6 blockade in treated HIV infection
$1,062,447Michael Marcel Lederman · Case Western Reserve University · U01 · FY2015 · AI
Antigen-specific NK cell memory
$1,062,410Georgia D Tomaras · Duke University · P01 · FY2020 · AI
MOLECULAR CLASSIFICATION OF COLON TUMORS
$1,062,380Montefiore Medical Center (Bronx, Ny) · U01 · FY2002 · CA
Effect of diflunisal (IND68092) on familial amyloidosis
$1,062,364John L Berk · Boston University Medical Campus · R01 · FY2006 · NS
University of Pennsylvania Patient-derived Xenograft Development and Trials Center
$1,062,215Martin Carroll · University Of Pennsylvania · U54 · FY2025 · CA
Pharmacology & human Phase 1 safety & dose escalation studies using anti-GP88 in aggressive breast cancer
$1,062,115Ginette Serrero · A And G Pharmaceutical, Inc. · R44 · FY2020 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,062,000Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,062,000David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Epigenetic regulation of cellular plasticity and cancer cell fate
$1,062,000Yang Shi · Boston Children'S Hospital · R35 · FY2018 · CA
Novel therapeutic development for small cell lung cancer
$1,062,000Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Towards targeting the lymphoma microenvironment
$1,062,000Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Novel therapeutic development for small cell lung cancer
$1,062,000Charles M Rudin · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
The TGFÃÂÃÂÃÂÃÂÃÂÃÂÃÂò Signaling Pathway in Development and Cancer
$1,062,000Joan Massague · Sloan-Kettering Inst Can Research · R35 · FY2025 · CA
Role of the Epitranscriptome in Cancer
$1,062,000Richard I. Gregory · Boston Children'S Hospital · R35 · FY2021 · CA